About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,985 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,985 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 801-820 of 7,985 trials

RecruitingSelective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1018.NCT06031246·Shanghai, Please Select WithdrawnA Study of ASP1893 in Adults With Advanced CLDN6-positive Solid TumorsBefore a treatment can be approved for use, clinical studies need to be done.NCT06681870

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedPhase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)This phase I trial studies the side effects and best dose of giving erlotinib and dovitinib together to treat patients with metastatic non-small cell lung cancer.NCT01515969·Stanford, California

CompletedTissue Microarrays (TMAs) Construction in Lung Cancer SamplesConstruction of a large cohort of lung cancer patients to evaluate the Prognostic and Predictive Significance of the molecular biomarkers Epidermal growth factor receptor (EGFR)…NCT03136523·Athens

CompletedA Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.This study was a randomized, single dose crossover comparison of the investigational product with a Reference Product (vinorelbine tartrate injection, NAVELBINE®).NCT00432562·Buenos Aires and 4 others

UnknownStudy of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLCThis randomized, Phase III, multicenter, open-label study designed to evaluate the efficacy of Atezolizumab in combination with carboplatin, paclitaxel, bevacizumab compared with…NCT03991403·Seoul, Gangnamgu

Active not recruitingLong-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%The purpose of this study is to assess the treatment-related adverse events and associated healthcare resource use in programmed death ligand 1 (PD-L1) negative individuals…NCT07215962·Fleming Island, Florida

TerminatedSafety Study: Combined Modality Treatment for Non-Small Cell Lung CancerThe purpose of this study is to determine the safety of using a treatment called transimmunization in addition to standard therapy (radiation) in the treatment of lung cancer.NCT00265603·Morristown, New Jersey

CompletedGemcitabine and Carboplatin for Elderly Patient With Lung CancerA comparison of biweekly combination chemotherapy (gemcitabine plus carboplatin) with weekly gemcitabine in elder patients (\> 75) with previously untreated advanced non-small…NCT00881296·Hamamatsu, Shizuoka

CompletedStudy of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for ChemotherapyThis is a Phase II open-label, single-arm, multicenter, international study to evaluate the clinical activity of durvalumab in patients with Stage III unresectable NSCLC who are…NCT04249362·Tucson, Arizona and 34 others

CompletedStudy of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsThe purpose of this study is to find out if panobinostat taken with cisplatin and pemetrexed can be used safely without increasing side effects and that the combination will have…NCT01336842·Sacramento, California and 1 other

CompletedTopotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00004979

Active not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCPDC-LUNG-101 trial is an open-label, dose-escalation, phase I/II study to assess the safety, the tolerability, the immunogenicity and the preliminary clinical activity of the…NCT03970746·Charleroi and 15 others

CompletedMaintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung CancerFor elderly patient, the treatment of Non Small Cell Lung Cancer was based on monotherapy but IFCT-0501 trial begun in 2006, demonstrated that a bitherapy (carboplatin and…NCT01850303·Abbeville and 77 others

Active not recruitingCCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung CancerThis phase I trial studies the side effects and best dose of autologous dendritic cell-adenovirus CCL21 vaccine (CCL21-gene modified dendritic cell vaccine) combined with…NCT03546361·Los Angeles, California

Active not recruitingBrain Oligometastasis in NSCLC75-80% of NSCLC are diagnosed at the metastatic stage. Among the most frequent sites are brain metastases.NCT07389642·Bordeaux

CompletedSasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced MalignanciesThis is a Phase 1b/2 protocol to evaluate pharmacokinetics, safety, efficacy, and pharmacodynamics of PF-06801591, a programmed death-1(PD-1) antagonist monoclonal antibody (mAb)…NCT04181788·Beijing, Beijing Municipality and 48 others

TerminatedADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-ImmunotherapyThis phase II trial studies two questions in patients with stage III NSCLC: 1) does it improve cancer control to add the drug Durvalumab, a type of immunotherapy, earlier in the…NCT04372927·Seattle, Washington

CompletedEthaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung CancersThioredoxin reductase plays an critical role in lung cancer patients, in vitro study showed that, ethaselen, specific inhibitor of thioredoxin reductase, could inhibit lung cancer…NCT02166242·Changsha, Hunan

TerminatedCarboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLCThis is a phase I/II study for previously untreated subjects with advanced NSCLC. The study will take place in two phases.NCT02382406·Duarte, California and 4 others

PreviousPage 41 of 400Next